0:07 [Music]
0:15 [Music]
0:31 [Music]
0:37 [Music]
0:40 respected principal secretary sir
0:43 MDNHM and our family wer and all the
0:47 officials Dr. from sir and sir I'm
0:51 extremely sorry for the confusion the
0:53 morning
0:54 sir some challenges um sir with regard
0:58 to
0:59 HD ma'am thank you JS ma'am for a nice
1:02 introduction ma'am it's a really great
1:05 and Dr. from was totally coordinating
1:09 from NIT in this and we are actively
1:12 participating and few things which we
1:16 like to do in fact sir used to talk
1:18 about this long
1:21 back few things which we personally
1:24 interested is that one is your health
1:26 benefit package see the whatever benefit
1:29 package which we are designed it depends
1:32 on many factors whether it is the
1:34 diagnostic or a treatment component or
1:37 the duration in which and the
1:39 effectiveness. See if you put all this
1:41 together only we can come to an a
1:43 conclusion of a health benefit package
1:46 as said by madam if you are able to
1:48 intervene correctly we can save more
1:50 than 300 to 400 cr in a package
1:53 particularly on insurance side that's a
1:56 huge benefit we can do it and if you
1:58 talk about simpler things which we on
2:00 day-to-day basis which are doing it so
2:03 cancer screening see there are so many
2:05 tests available like it could be a
2:07 simple b test or it could be a papsmear
2:11 and otherwise it could be your HPV DNA
2:14 testing. See all are available all are
2:18 approved by the agency. But what is more
2:22 important is it's not only about the
2:24 clinical effectiveness but also about
2:27 the cost effectiveness, ethical
2:29 consideration and also feasibility you
2:32 implement in the field. See when you are
2:34 reaching a crowd of population in this
2:36 type of intervention we should able to
2:39 come to a solution which is practiced by
2:42 each and everyone at the same time gives
2:44 a really good sensitive results and is
2:47 cost effective. So this is where the
2:49 role is there. Though we are right now
2:52 going ahead with the via in the field
2:55 screening for the cancer there's a huge
2:57 potential to go for an HPV DNA. See it
3:00 may be cost right now but when you put
3:03 it in the field and considering the
3:06 results which you are getting through
3:07 via it may be another alternative and in
3:11 my previous session we to talk about an
3:13 primary PCI. See the primary PCI yes it
3:17 is good but it takes away the totally
3:20 the component called your management
3:24 medical management or it takes away the
3:26 provision for your uh CABG see the
3:30 primary PCA yes it's good it saves life
3:34 but at what cost whether you totally
3:36 take away what is we call it as a
3:38 conservative management there's no role
3:41 for conservative management when you go
3:42 for a primary PCA at the Same way your
3:45 CPG is taken out and another simple
3:48 challenges which we face right now is
3:50 your anemia management. We all
3:53 wonderfully talking about weekly iron
3:55 and folic acid but the commercial is
3:58 talking about FCM and similarly in
4:01 between we have an iron and sucrose
4:03 injections. So iron and sucrose we need
4:06 to come in person give it in a weekly
4:08 basis. FCM it is costlier but we can
4:11 reduce the duration and the number of
4:13 contacts. The weekly iron and folic acid
4:16 is a very easy to implement, highly cost
4:19 effective. And when you see the final
4:21 result which is most effective which was
4:24 we need to assess though it looks
4:26 simpler and other negative aspect is
4:29 also there during co there are lot of
4:33 rapid kits that come everyone is flooded
4:36 with the market but which one is most
4:38 effective at the time we consciously
4:40 took a decision to go for a RTPCR though
4:44 it was a costlier but it gives a result
4:46 and we could do an immediate
4:48 intervention of preventing the spread.
4:50 So there are many other examples. Thank
4:53 you very much for opportunity. Next time
4:55 it will not happen. We'll see that we'll
4:57 have a further detailed assessment.
5:00 Thank you very much, sir. Thank you.
5:03 [Music]
Chrome Extension